Business & Strategy•Aug 5, 2026•PR Newswire FDAAveva Drug Delivery Systems prevails on appeal, Federal Circuit affirms non-infringement of ZTlido patents ↗The Federal Circuit affirmed a district court ruling that Aveva Drug Delivery Systems' generic ZTlido product does not infringe Scilex's patents, preparing the company for an imminent launch of its generic product with 180-day exclusivity.
Clinical Regulatory•Jul 27, 2026•PR Newswire FDADifGen Pharmaceuticals Receives FDA Clearance to Begin Clinical Development for a Single Injection treatment for Advanced Breast Cancer DFGN-101 ↗DifGen Pharmaceuticals Receives FDA Clearance to Begin Clinical Development for a Single Injection treatment for Advanced Breast Cancer DFGN-101.